These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18513211)

  • 1. Conformational (in)stability of rat vs. human activated thrombin activatable fibrinolysis inhibitor.
    Hillmayer K; Ceresa E; Vancraenenbroeck R; Declerck PJ; Gils A
    J Thromb Haemost; 2008 Aug; 6(8):1426-8. PubMed ID: 18513211
    [No Abstract]   [Full Text] [Related]  

  • 2. Generation of a stable thrombin-activatable fibrinolysis inhibitor deletion mutant exerting full carboxypeptidase activity without activation.
    Zhou X; Declerck PJ
    J Thromb Haemost; 2015 Jun; 13(6):1084-9. PubMed ID: 25773535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the substrate binding site of thrombin-activatable fibrinolysis inhibitor (TAFI) alter its substrate specificity.
    Zhao L; Buckman B; Seto M; Morser J; Nagashima M
    J Biol Chem; 2003 Aug; 278(34):32359-66. PubMed ID: 12799375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments in thrombin-activatable fibrinolysis inhibitor research.
    Marx PF; Verkleij CJ; Valls Seron M; Meijers JC
    Mini Rev Med Chem; 2009 Sep; 9(10):1165-73. PubMed ID: 19534693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of rat thrombin-activatable fibrinolysis inhibitor (TAFI)--a comparative study assessing the biological equivalence of rat, murine and human TAFI.
    Hillmayer K; Macovei A; Pauwels D; Compernolle G; Declerck PJ; Gils A
    J Thromb Haemost; 2006 Nov; 4(11):2470-7. PubMed ID: 17002650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a thrombomodulin interaction site on thrombin-activatable fibrinolysis inhibitor that mediates accelerated activation by thrombin.
    Marar TT; Boffa MB
    J Thromb Haemost; 2016 Apr; 14(4):772-83. PubMed ID: 26816270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of isoleucine residues 182 and 183 in thrombin-activatable fibrinolysis inhibitor.
    Marx PF; Havik SR; Bouma BN; Meijers JC
    J Thromb Haemost; 2005 Jun; 3(6):1293-300. PubMed ID: 15946220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased zymogen activity of thrombin-activatable fibrinolysis inhibitor prolongs clot lysis.
    Mishra N; Buelens K; Theyskens S; Compernolle G; Gils A; Declerck PJ
    J Thromb Haemost; 2012 Jun; 10(6):1091-9. PubMed ID: 22498006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical characterization of bovine plasma thrombin-activatable fibrinolysis inhibitor (TAFI).
    Valnickova Z; Thaysen-Andersen M; Højrup P; Christensen T; Sanggaard KW; Kristensen T; Enghild JJ
    BMC Biochem; 2009 May; 10():13. PubMed ID: 19416536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidation of the molecular mechanisms of two nanobodies that inhibit thrombin-activatable fibrinolysis inhibitor activation and activated thrombin-activatable fibrinolysis inhibitor activity.
    Zhou X; Weeks SD; Ameloot P; Callewaert N; Strelkov SV; Declerck PJ
    J Thromb Haemost; 2016 Aug; 14(8):1629-38. PubMed ID: 27279497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of activated thrombin-activatable fibrinolysis inhibitor, a molecular link between coagulation and fibrinolysis.
    Sanglas L; Valnickova Z; Arolas JL; Pallarés I; Guevara T; Solà M; Kristensen T; Enghild JJ; Aviles FX; Gomis-Rüth FX
    Mol Cell; 2008 Aug; 31(4):598-606. PubMed ID: 18722183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective modulation of thrombin-activatable fibrinolysis inhibitor (TAFI) activation by thrombin or the thrombin-thrombomodulin complex using TAFI-derived peptides.
    Plug T; Marquart JA; Marx PF; Meijers JC
    J Thromb Haemost; 2015 Nov; 13(11):2093-101. PubMed ID: 26341360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into factors affecting clot stability: A role for thrombin activatable fibrinolysis inhibitor (TAFI; plasma procarboxypeptidase B, plasma procarboxypeptidase U, procarboxypeptidase R).
    Bouma BN; Meijers JC
    Semin Hematol; 2004 Jan; 41(1 Suppl 1):13-9. PubMed ID: 14872415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a stable activated thrombin activable fibrinolysis inhibitor variant.
    Ceresa E; Van de Borne K; Peeters M; Lijnen HR; Declerck PJ; Gils A
    J Biol Chem; 2006 Jun; 281(23):15878-83. PubMed ID: 16595693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of stable TAFIa variants: importance of alpha-helix 9 and beta-sheet 11 for TAFIa (in)stability.
    Ceresa E; De Maeyer M; Jonckheer A; Peeters M; Engelborghs Y; Declerck PJ; Gils A
    J Thromb Haemost; 2007 Oct; 5(10):2105-12. PubMed ID: 17666015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of thrombin-activatable fibrinolysis inhibitor (TAFI) is up-regulated by increase in intracellular cyclic AMP levels in cultured HepG2 cells.
    Ishii H; Kojima Y; Masuda Y; Takada K; Sugimoto K; Ikeda T
    Thromb Haemost; 2009 Dec; 102(6):1204-11. PubMed ID: 19967152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino acid residues in the P6-P'3 region of thrombin-activable fibrinolysis inhibitor (TAFI) do not determine the thrombomodulin dependence of TAFI activation.
    Schneider M; Nagashima M; Knappe S; Zhao L; Morser J; Nesheim M
    J Biol Chem; 2002 Mar; 277(12):9944-51. PubMed ID: 11786552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin-activatable fibrinolysis inhibitor binds to Streptococcus pyogenes by interacting with collagen-like proteins A and B.
    Påhlman LI; Marx PF; Mörgelin M; Lukomski S; Meijers JC; Herwald H
    J Biol Chem; 2007 Aug; 282(34):24873-81. PubMed ID: 17553807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of thrombomodulin mutation causing defective thrombin binding with absence of protein C and TAFI activation.
    Okada M; Tominaga N; Honda G; Nishioka J; Akita N; Hayashi T; Suzuki K; Moriuchi H
    Blood Adv; 2020 Jun; 4(12):2631-2639. PubMed ID: 32556284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review.
    Sillen M; Declerck PJ
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.